UNSPSC 51343116: Azidothymidine or zidovudine

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B9XT59T7S. European Medicines Agency schedules Zidovudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00153MIG. Zidovudine generally arises in the molecular formula C10H13N5O4.

The term ZIDOVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) ZIDOVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Azidothymidine or zidovudine bears US NLM identifiers UMLS ID C0043474 and NCI Concept Code C947. SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-].

UNSPSC 51343116 Azidothymidine or zidovudine is a Commodity code that nominally names a specific antiretroviral pharmaceutical product, but the recent state and local opportunities posted under it do not reflect procurement of that drug. Instead, the tagged solicitations involve naloxone (an opioid-overdose reversal agent) and doxycycline and ciprofloxacin (broad-spectrum antibiotics). State and local health departments and county public-health authorities use this code—or codes semantically similar to it in their procurement systems—to source pharmaceutical products for emergency response, disease prevention, and community-health initiatives. The work involves supplier selection through competitive bidding, negotiation of unit pricing, specification of packaging and expiration requirements, and management of quarterly or standing inventory replenishment agreements, often via cooperative purchasing vehicles such as MMCAP.

Recent activity spans Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392, IFB process) for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets with a 12-month initial term and two renewal options. Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract includes a two-year initial term plus one renewal option, drug-free workplace certification, and E-Verify compliance requirements. The code shows limited recent activity, and the mismatch between the code's nominal scope (azidothymidine) and actual procurements suggests that state procurement systems may be misapplying this or related codes to general pharmaceutical supply contracts. Bidders pursuing this space should verify code alignment with issuing bodies during pre-bid Q&A and prioritize experience with cooperative purchasing agreements and state-health-department supply chains.